{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:02:45Z","timestamp":1791079365248,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.exphem.2007.08.025","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T09:55:16Z","timestamp":1196762116000},"page":"1668-1676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V&gt;F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms"],"prefix":"10.1016","volume":"35","author":[{"given":"Vesna","family":"Najfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Windy","family":"Berkofsy-Fessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Prchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Scalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2007.08.025_bib1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2007.08.025_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/315758a0","article-title":"Structural organization of the bcr gene and its role in the Ph' translocation","volume":"315","author":"Heisterkamp","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2007.08.025_bib4","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on the Polycythemia Vera Study Group protocols","volume":"23","author":"Berk","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2007.08.025_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","article-title":"A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib6","first-page":"224","article-title":"Karyotype and molecular cytogenetic studies in polycythemia vera","volume":"4","author":"Andrieux","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.exphem.2007.08.025_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.seminoncol.2005.04.007","article-title":"Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia","volume":"32","author":"Reilly","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.exphem.2007.08.025_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00277-004-0977-1","article-title":"Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information","volume":"84","author":"Bacher","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2007.08.025_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1365-2141.2002.03763.x","article-title":"Exploring polycythemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected","volume":"119","author":"Najfeld","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2007.08.025_bib10","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib11","unstructured":"Chronic myeloproliferative disease (MPD). Atlas of Genetics and Cytogenetics in Oncology and Haematology. Available at: http:\/\/atlasgeneticsoncology.org\/Anomalies\/Anomliste.html#MPD. Accessed."},{"key":"10.1016\/j.exphem.2007.08.025_bib12","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2007.08.025_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2007.08.025_bib15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2007.08.025_bib16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based study on JAK2 V617F mutation status: a prospective study","volume":"356","author":"Campbell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2007.08.025_bib17","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome\u2013negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib18","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and myelodysplastic syndromes","volume":"106","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib19","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1182\/blood-2005-09-3900","article-title":"X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET\/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis","volume":"107","author":"Levine","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","article-title":"Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera","volume":"30","author":"Kralovics","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2007.08.025_bib21","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V90.7.2535","article-title":"Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia","volume":"90","author":"Peeters","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/gcc.20235","article-title":"A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia","volume":"44","author":"Griesinger","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2007.08.025_bib23","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1158\/0008-5472.CAN-04-4263","article-title":"The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCMI to JAK2","volume":"65","author":"Reiter","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2007.08.025_bib24","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood-2006-04-014712","article-title":"JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model","volume":"108","author":"Mercher","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gde.2006.12.009","article-title":"JAK2: normal function and role in hematopoietic disorders","volume":"17","author":"Ihle","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.exphem.2007.08.025_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2007.08.025_bib27","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood-2006-09-045963","article-title":"Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia","volume":"109","author":"Malinge","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/sj.leu.2404086","article-title":"JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report of 349 patients","volume":"20","author":"Vizmanos","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2007.08.025_bib29","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2007.08.025_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-4608(88)90029-5","article-title":"Transformation of polycythemia vera to acute nonlymphocytic leukemia accompanied by t(1;3)(p36;q21) karyotype","volume":"33","author":"Najfeld","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2007.08.025_bib31","series-title":"An International System for Human Cytogenetic Nomenclature","year":"2005"},{"key":"10.1016\/j.exphem.2007.08.025_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2006.11.012","article-title":"Polycythemia vera is not initiated by JAK2V617F mutation","volume":"35","author":"Nussenzveig","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2007.08.025_bib33","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2006-01-013540","article-title":"The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera","volume":"108","author":"Lippert","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib34","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00018-006-6272-7","article-title":"Oncogenic mechanisms in myeloproliferative disorders","volume":"63","author":"Delhommeau","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.exphem.2007.08.025_bib35","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2005-12-013748","article-title":"Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations and role in leukemic transformation","volume":"108","author":"Campbell","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib36","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/sj.leu.2404707","article-title":"JAK2V617F as a progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases","volume":"21","author":"Schnittger","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2007.08.025_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I","article-title":"Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line","volume":"30","author":"Bentz","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2007.08.025_bib38","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":"Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene","volume":"87","author":"Joos","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib39","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation","volume":"108","author":"Szpurka","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2005.05416.x","article-title":"Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2","volume":"129","author":"Goerttler","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2007.08.025_bib41","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood-2005-05-1889","article-title":"Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2","volume":"106","author":"Kralovics","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib42","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1093\/emboj\/17.18.5321","article-title":"Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL\/JAK2 fusion genes","volume":"17","author":"Schwaller","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2007.08.025_bib43","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1182\/blood.V95.12.3891","article-title":"TEL-JAK2 transgenic mice develop T-cell leukemia","volume":"95","author":"Carron","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib44","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V95.6.2076","article-title":"Transforming properties of chimeric TEL-JAK proteins in Ba\/F3 cells","volume":"95","author":"Lacronique","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.08.025_bib45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.exphem.2004.10.019","article-title":"Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion","volume":"33","author":"Onnebo","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2007.08.025_bib46","unstructured":"Najfeld, V. Conventional and molecular cytogenetics of ph-negative chronic myeloproliferative disorders. In: Tefferi A, Silver R, eds. Myeloproliferative Disorders: Molecular Pathogenesis and Practice in the JAK2 Mutations Era. Abingdon, UK: Informa Healthcare; in press."},{"key":"10.1016\/j.exphem.2007.08.025_bib47","unstructured":"Atlas of Genetics and Cytogenetics in Oncology and Haematology. Available at: http:\/\/atlasgeneticsoncology.org\/Genes\/AML1.html. Accessed."},{"key":"10.1016\/j.exphem.2007.08.025_bib48","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.93.8.3444","article-title":"Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis","volume":"93","author":"Wang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2007.08.025_bib49","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"Lacronique","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.exphem.2007.08.025_bib50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.leu.2404026","article-title":"A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma\/leukemia","volume":"20","author":"dos Santos","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2007.08.025_bib51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.leu.2404072","article-title":"Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases","volume":"20","author":"Desta","year":"2006","journal-title":"Leukemia"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X07005346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X07005346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:23:50Z","timestamp":1759566230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X07005346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0301472X07005346"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2007.08.025","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2007.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}